Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains?

Zacks
Abrir en Zacks
Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains?

Alcon ALC shares ended the last trading session 6.8% higher at $77.31. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 14.5% gain over the past four weeks.

Alcon scored a strong price increase on investors’ optimism surrounding the company’s impending third quarter 2026 financial results, which is expected to release on Nov. 11. The Zacks Consensus Estimate for the third quarter revenue suggests an increase of 5.6% and the earnings share is expected to improve 12.7%.

This company is expected to post quarterly earnings of $0.89 per share in its upcoming report, which represents a year-over-year change of +12.7%. Revenues are expected to be $2.73 billion, up 5.6% from the year-ago quarter.

While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For Alcon, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on ALC going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Alcon is part of the Zacks Medical - Instruments industry. NeuroPace, Inc. NPCE, another stock in the same industry, closed the last trading session 8.4% higher at $13.34. NPCE has returned -2.8% in the past month.

For NeuroPace, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.06. This represents a change of +45.5% from what the company reported a year ago. NeuroPace currently has a Zacks Rank of #3 (Hold).

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.

See Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Alcon (ALC): Free Stock Analysis Report
 
NeuroPace, Inc. (NPCE): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research